Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Medpace Holdings, Inc.

Get SEC filing alerts via email and in your feed for Medpace Holdings, Inc.

MEDP

Medpace Holdings, Inc.

About Medpace Holdings, Inc.

Medpace Holdings, Inc. is a global clinical contract research organization (CRO) providing full-service Phase I-IV clinical development services to the biotech, pharmaceutical, and medical device industries. Focused on therapeutic areas like Oncology, CNS, and Cardiovascular, it supports drug development through trial management, regulatory guidance, data sciences, and laboratory services. Its business model emphasizes quality, efficiency, and deep therapeutic expertise to serve small and mid-sized biopharma companies worldwide.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Medpace Holdings, Inc.

1
1
Medpace Holdings, Inc. Medpace Holdings Reports 26.5% Revenue Growth to $706.6 Million in Latest Quarter

Via official filing (AI summary) | about 2 months ago | 0 comments

2
1
Medpace Holdings, Inc. Medpace Holdings Reports 20% Revenue Growth to $2.53 Billion for Fiscal Year 2025

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
Medpace Holdings, Inc. Medpace Holdings Reports 23.7% Revenue Growth to $659.9 Million in Latest Quarter

Via official filing (AI summary) | 8 months ago | 0 comments

4
1
Medpace Holdings, Inc. Medpace Holdings Reports 14.2% Revenue Growth to $603.3 Million in Q2 2025

Via official filing (AI summary) | 11 months ago | 0 comments

5
1
Medpace Holdings, Inc. Medpace Holdings Reports 9.3% Revenue Growth to $558.6 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Medpace Holdings, Inc. Medpace Holdings Reports 11.8% Revenue Growth to $2.11 Billion for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
Medpace Holdings, Inc. Medpace Holdings Reports Strong Q3 and Nine-Month Financial Results with Revenue and Net Income Growth

Via official filing (AI summary) | over 1 year ago | 0 comments